Ivenix Infusion System (IIS)
Recall Z-1381-2022, part of FDA recall event 90314. See Ivenix's company page.
Ivenix, Inc. started this Class II device recall on Apr 22, 2022 (voluntary: firm initiated); FDA lists it as terminated, terminated May 20, 2024.
- Classification: Class II
- Started: Apr 22, 2022
- Status: Terminated
Downstream occlusion alarm is sometimes immediately followed by a pump problem alarm.
- Product
- Ivenix Infusion System (IIS)
- Quantity
- 1335 devices
- Lots and codes
- UDI-DI: LVP-SW-0004 Software version 5.0 System serial numbers: 2118200011 2119300411 2119300414 2119300415 2119300417 2119300418 2119300421 2119300422 2119300423 2119300424 2119300425 2119300426 2119300427 2119300428 2119300429 2119300430 2119300431 2119300432 2119300434 2119300435 2119300436 2119300437 2119300438 2119300439 2119300440 2119300441 2119300442 2124300050 2124300051 2124300052 2124300055 2124300058 2124300062 2124300067 2124300068 2124300070 2124300073 2124300074 2124300076 2124300078 2124300079 2124300081 2124300082 2124300084 2124300086 2124300087 2124300088 2124300089โฆ
- Distribution
- US Nationwide distribution in the states of NJ and WI.
- Recalling firm
- Ivenix, Inc., North Andover, MA, United States
- How the firm notified
- Letter
- FDA classified
- Jul 13, 2022
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports